US2021100851A1PendingUtilityA1

Bacillus bacterium, interleukin-22 production inducing agent, skin barrier function enhancing agent

56
Assignee: ICHIBIKI CO LTDPriority: Feb 16, 2018Filed: Feb 15, 2019Published: Apr 8, 2021
Est. expiryFeb 16, 2038(~11.6 yrs left)· nominal 20-yr term from priority
Inventors:Toshihiko KumazawaAtsuhisa NishimuraNoriyuki AsaiTakahiro Adachi
C12R 2001/07C12N 1/205A61P 37/04A61P 17/16A61K 35/742A61Q 17/00A61K 8/99A61Q 19/00C12N 1/20A61K 35/747A61P 17/00C12R 1/07
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A Bacillus bacterium that induces the production of interleukin-22 is provided. The Bacillus bacterium that induces the production of interleukin-22.

Claims

exact text as granted — not AI-modified
1 . A  Bacillus  bacterium that induces the production of interleukin-22. 
     
     
         2 . The  Bacillus  bacterium according to  claim 1 , wherein the  Bacillus  bacterium has the potency to improve the viability of B cells and the activation potency of B cells. 
     
     
         3 . The  Bacillus  bacterium according to  claim 1 , wherein the  Bacillus  bacterium is derived from foods. 
     
     
         4 . The  Bacillus  bacterium according to  claim 1 , wherein the  Bacillus  bacterium is derived from miso or natto. 
     
     
         5 . The  Bacillus  bacterium according to  claim 1 , wherein the  Bacillus  bacterium belongs to at least one selected from the group consisting of  Bacillus subtilis  and  Bacillus coagulans.    
     
     
         6 . The  Bacillus  bacterium according to  claim 1 , wherein the  Bacillus  bacterium is a  Bacillus  bacterium of Accession number NITE BP-02583, a  Bacillus  bacterium of Accession number NITE BP-02584, or a  Bacillus  bacterium of Accession number NITE BP-02590. 
     
     
         7 . An interleukin-22 production inducing agent containing the  Bacillus  bacterium according to  claim 1 . 
     
     
         8 . A skin barrier function enhancing agent containing the  Bacillus  bacterium according to  claim 1 . 
     
     
         9 . The  Bacillus  bacterium according to  claim 2 , wherein the  Bacillus  bacterium is derived from foods. 
     
     
         10 . The  Bacillus  bacterium according to  claim 2 , wherein the  Bacillus  bacterium is derived from miso or natto. 
     
     
         11 . The  Bacillus  bacterium according to  claim 3 , wherein the  Bacillus  bacterium is derived from miso or natto. 
     
     
         12 . The  Bacillus  bacterium according to  claim 2 , wherein the  Bacillus  bacterium belongs to at least one selected from the group consisting of  Bacillus subtilis  and  Bacillus coagulans.    
     
     
         13 . The  Bacillus  bacterium according to  claim 3 , wherein the  Bacillus  bacterium belongs to at least one selected from the group consisting of  Bacillus subtilis  and  Bacillus coagulans.    
     
     
         14 . The  Bacillus  bacterium according to  claim 4 , wherein the  Bacillus  bacterium belongs to at least one selected from the group consisting of  Bacillus subtilis  and  Bacillus coagulans.    
     
     
         15 . The  Bacillus  bacterium according to  claim 2 , wherein the  Bacillus  bacterium is a  Bacillus  bacterium of Accession number NITE BP-02583, a  Bacillus  bacterium of Accession number NITE BP-02584, or a  Bacillus  bacterium of Accession number NITE BP-02590. 
     
     
         16 . The  Bacillus  bacterium according to  claim 3 , wherein the  Bacillus  bacterium is a  Bacillus  bacterium of Accession number NITE BP-02583, a  Bacillus  bacterium of Accession number NITE BP-02584, or a  Bacillus  bacterium of Accession number NITE BP-02590. 
     
     
         17 . An interleukin-22 production inducing agent containing the  Bacillus  bacterium according to  claim 2 . 
     
     
         18 . An interleukin-22 production inducing agent containing the  Bacillus  bacterium according to  claim 3 . 
     
     
         19 . A skin barrier function enhancing agent containing the  Bacillus  bacterium according to  claim 2 . 
     
     
         20 . A skin barrier function enhancing agent containing the  Bacillus  bacterium according to  claim 3 .

Join the waitlist — get patent alerts

Track US2021100851A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.